Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 626-637, April 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Röller, M.-R.
Right arrow Articles by Heidelberger, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Röller, M.-R.
Right arrow Articles by Heidelberger, C.

Studies on the Organ Culture of Human Tumors1

Manuela-R. Röller, Stanley P. Owen2 and Charles Heidelberger3

McArdle Laboratory, The Medical School, University of Wisconsin, Madison, Wisconsin

Ninety-one surgical specimens of human tumors were cultivated in organ culture in Eagle's MEM medium supplemented with various sources of protein, and their viability was evaluated histologically after 4, 7, and 11 days of cultivation. There was an over-all viability of 43%, and the viable specimens retained the histologic characteristics of the original tumors. The tumors included 42 gastrointestinal tumors, 19 breast tumors, 21 miscellaneous tumors, and 9 glandular tumors, of which the last group exhibited the best viability in culture. The best protein supplement to the medium was found to be the patient's own serum.

1 This work was supported in part by Grants CA-7175 and CRTY-5002 from the National Cancer Institute, USPHS, and from The Upjohn Company, Kalamazoo, Mich.

2 On leave from, and present address, Research Division, The Upjohn Company, Kalamazoo, Michigan.

3 American Cancer Society Professor of Oncology.

Received 8/ 9/65.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.